Skip to main content

Year: 2019

JLT Mobile Computers stärkt seine führende Position auf dem robusten Computermarkt durch Aufrüstung der VERSO-Serie

JLT Mobile Computers stärkt seine führende Position auf dem robusten Computermarkt durch Aufrüstung der VERSO™-SerieDank einer bis zu 70% höheren Leistungssteigerung sind komplexe Anwendungen wie Echtzeit-Videoanalyse und grafische Animation nun auch im anspruchsvollen Umfeld von z.B. Bergbau, Öl- & Gasindustrie oder Landwirtschaft möglichVäxjö, Schweden, 11. Dezember 2019   * * *   JLT Mobile Computers, ein führender Entwickler und Hersteller robuster Computer für anspruchsvolle Einsatzumgebungen, hat die Fahrzeugcomputer seiner VERSO™-Serie aufgerüstet. Kunden mit hohen Rechenleistungsanforderungen haben nun die Wahl zwischen leistungsstarken, hochmodernen Intel® Core™ i3 oder Core™ i7 Prozessoren mit der Kaby Lake CPU-Architektur der 7. Generation.  Durch die Aufrüstung der VERSO-Serie festigt JLT seine Führungsposition als Anbieter...

Continue reading

JLT Mobile Computers consolida la sua posizione di leader nelle prestazioni dei terminali rugged, con l’evoluzione della serie VERSO

JLT Mobile Computers consolida la sua posizione di leader nelle prestazioni dei terminali rugged, con l’evoluzione della serie VERSO™Con un incremento delle prestazioni fino al 70% l’Azienda consente la realizzazione di applicazioni avanzate, con analisi video e animazioni grafiche in tempo reale, in settori quali industria estrattiva, petrolchimico e agricoltura.Växjö, Svezia, 11 Dicembre 2019   * * *   JLT Mobile Computers, produttore e fornitore leader di terminali veicolari affidabili per gli ambienti di lavoro più esigenti, annuncia il lancio dei nuovi modelli aggiornati di terminali della serie VERSO™. I clienti che hanno esigenza di avere performance elevate in termini di prestazioni o di calcolo, hanno ora a disposizione processori avanzati come Intel® Core™ i3 o Core™ i7, con architettura CPU Kaby Lake di settima...

Continue reading

JLT Mobile Computers refuerza su posición de líder en el sector de los ordenadores robustos con la serie VERSO actualizada

JLT Mobile Computers refuerza su posición de líder en el sector de los ordenadores robustos con la serie VERSO™ actualizadaHasta un 70 % de mejora de prestaciones para aplicaciones avanzadas, en particular el análisis de vídeo en tiempo real y las animaciones gráficas en sectores como la minería, el petróleo y el gas y la agriculturaVäxjö, Suecia, 11 de diciembre de 2019  * * *  JLT Mobile Computers, uno de los principales proveedores de ordenadores fiables para entornos exigentes, anuncia el lanzamiento de sus ordenadores montados en vehículos de la serie VERSO™ actualizados. Los clientes con altas exigencias de rendimiento informático pueden elegir ahora entre potentes procesadores Intel® Core™ i3 o Core™ i7 de tecnología puntera con la arquitectura de CPU Kaby Lake de séptima generación.Con sus ordenadores VERSO actualizados, JLT refuerza...

Continue reading

Karolinska Development’s portfolio company Forendo Pharma enters license and collaboration agreement with leading pharma company

STOCKHOLM, SWEDEN – December 11, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company Forendo Pharma has entered a license and collaboration agreement with the global pharmaceutical company Novartis to develop new drugs for the treatment of chronic liver diseases. Forendo is entitled to an upfront payment, milestone payments and sales-based royalties on products emanating from the research collaboration, which is to be entirely funded by Novartis. In conjunction with the initiation of the collaboration, Novartis will make an equity investment in Forendo.The collaboration is based on Forendo’s world-leading expertise in drug discovery and development of HSD17B inhibitors, which has potential to become effective treatments for a wide range of diseases. HSD17B is a class of enzymes that regulates...

Continue reading

Karolinska Developments portföljbolag Forendo Pharma ingår licens- och samarbetsavtal med globalt läkemedelsföretag

STOCKHOLM, SVERIGE 11 december 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Forendo Pharma har ingått ett licens- och samarbetsavtal med det globala läkemedelsföretaget Novartis för att utveckla nya läkemedel mot kroniska leversjukdomar. Forendo erhåller en initial kontantersättning och har rätt till milstolpsbetalningar samt försäljningsbaserade royalties på produkter som genereras i forskningssamarbetet, vilket i sin helhet kommer att finansieras av Novartis. I samband med initieringen av samarbetet genomför Novartis en aktieinvestering i bolaget.Samarbetet baseras på Forendos världsledande kompetens inom utveckling av HSD17B-hämmare. HSD17B är en enzymklass som reglerar vävnadsspecifika hormonmekanismer och bedöms spela en viktig roll vid en lång rad olika sjukdomstillstånd. Novartis kommer...

Continue reading

CATANA GROUP : PROTOCOLE D’ACCORD POUR L’ACQUISITION DU CHANTIER MAGIC YACHTS EN TUNISIEVERS UN RENFORCEMENT SIGNIFICATIF DU DISPOSITIF INDUSTRIEL DU GROUPE

Communiqué de Presse                                                                               Canet-en-Roussillon, le 11 décembre cCATANA GROUPPROTOCOLE D’ACCORD POUR L’ACQUISITIONDU CHANTIER MAGIC YACHTS EN TUNISIEVERS UN RENFORCEMENT SIGNIFICATIF DU DISPOSITIF INDUSTRIEL DU GROUPEAu terme d’une cinquième année de croissance annuelle moyenne de plus 50% et d’un carnet de commandes qui permettra cette année de dépasser le seuil de 100 M€ de chiffre d’affaires, CATANA Group vient de signer une promesse d’acquisition de la majorité du capital de la société MAGIC YACHTS.MAGIC YACHTS situé en Tunisie, a repris en 2012 le chantier naval fondé en 1999 par le constructeur de bateaux de luxe monégasque, WALLY.MAGIC YACHTS dispose en zone franche de Bizerte d’un site exceptionnel en bordure de mer de près de 30 000 m² dont plus de 10 000...

Continue reading

INVL Baltic Forests Fund I managed by INVL Asset Management, a subsidiary of Invalda INVL, completes forest-sale transaction

Please note that this information is announced in the Other Information category.The INVL Baltic Forests Fund I managed by INVL Asset Management, one of Lithuania’s leading asset management companies, sold 4 300 hectares of forest in Lithuania. Silvestica Green Forest Lithuania acquired the companies Aukštašilė and Aukštagirė, which owned most of the fund’s forest portfolio. The size of the transaction is not being made public.“This transaction is an acknowledgement of the fund’s nearly three years of operations. Acting in accordance with the principles of sustainable forestry, we formed a portfolio of quality forest. We plan to continue those efforts, applying the best practices in this field with a focus on responsible and sustainable forest management,” said Sigita Bizulienė, the manager of the INVL Baltic Forests Fund I.“We are very...

Continue reading

„Invaldos INVL“ dukterinės bendrovės „INVL Asset Management“ valdomas „INVL Baltijos miškų fondas I“ baigė miškų pardavimo sandorį

Atkreipiame dėmesį, kad šis pranešimas skelbiamas kategorijoje „Kita informacija“. Vienos pirmaujančių turto valdymo bendrovių Lietuvoje „INVL Asset Management“ valdomas „INVL Baltijos miškų fondas I“ pardavė 4,3 tūkst. hektarų miško Lietuvoje. Didžiąją dalį fondo miškų portfelio valdžiusias bendroves „Aukštašilė“ ir „Aukštagirė“ įsigijo bendrovė „Silvestica Green Forest Lithuania“. Sandorio suma neskelbiama.„Šis sandoris – tai beveik trejų metų fondo veiklos įvertinimas. Veikdami tvarios miškininkystės principais, suformavome kokybiško miško portfelį. Orientuodamiesi į atsakingą ir tvarų miškų valdymą pritaikant gerąsias šios srities praktikas, planuojame šiuos darbus tęsti ir toliau“, – sakė „INVL Baltijos miškų fondo I“ valdytoja Sigita Bizulienė.„Džiaugiamės įsigiję šį didelį miškų portfelį, kurį sudaro gerai prižiūrėti miškai,...

Continue reading

Additional Listing

LEI: 213800WTQKOQI8ELD692OneSavings Bank plc(the Company)                                                        Block ListingA block listing application has been made to the UK Listing Authority for a total of 2,750,000 Ordinary Shares of £0.01 each (the Shares) of the Company to be admitted to the Official List of the UK Listing Authority. An application has also been made to the London Stock Exchange for the Shares to be admitted to trading.  The Shares shall rank equally with the existing issued Shares of the Company. Admission is expected on or around 12 December 2019. The Shares will be allotted from time to time following the exercise of options pursuant to the Company’s Sharesave Scheme (1,100,000); and vestings under the Deferred Share Bonus Plan (1,150,000) and Performance Share Plan (500,000). Enquiries:OneSavings Bank plcNickesha...

Continue reading

Disclosure of Voting Rights in IDEX Biometrics – Chair Morten Opstad – 10 Dec 2019

At the close of business on 10 December 2019, Morten Opstad, Chair of the Board of Directors of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the extraordinary general meeting on 12 December 2019:Total  203,107,795 shares or 31.08% of the share capital and votes, consisting of the following:Proxy to represent and vote for  98,120,688 shares or 15.02% of the share capitalMr. Opstad and close associates hold  7,298,916 shares or 1.12% of the share capitalProxy with voting instructions for  97,688,191 shares or 14.95% of the share capitalFor further information contact:Derek P. D’Antilio, CPAChief Financial OfficerTel: +1 978 273 1344derek.dantilio@idexbiometrics.comErling SvelaVP FinanceTel: +47 4062 1040erling.svela@idexbiometrics.comAbout IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.